OpenEvidence has spread through hospitals faster than almost any clinical tool I can remember, and heme/onc fellows are among its heaviest users. The pitch is simple: ask a clinical question in plain language and get a synthesized, cited answer drawn from the medical literature. The question for a fellow is whether it earns a spot in your daily workflow. My honest take as a practicing oncologist: yes, OpenEvidence is worth it, it is free for verified clinicians, and it is genuinely useful on rounds and at tumor board, as long as you treat it as a fast evidence lookup and not the final word.
TL;DR
OpenEvidence is a free AI tool for verified clinicians that answers clinical questions by synthesizing cited evidence from the medical literature, including sources like NEJM and JAMA.
For heme/onc fellows it is most useful at the point of care: dosing, drug interactions, second and third line options, and quick evidence checks before tumor board.
It is built for clinical decision support, not structured board study, so it complements a question bank rather than replacing one.
Its grounding in cited sources makes it far safer than a general chatbot, but it can still err, so verify high stakes details against the primary trial or guideline.
It is backed by the Mayo Clinic Platform and a physician advisory board, which is part of why adoption has been so fast.
What is OpenEvidence?
OpenEvidence is an AI medical information tool that answers clinical questions by searching and synthesizing the peer reviewed literature, then giving you a written answer with linked citations. Instead of returning a list of papers like a database search, it reads across the evidence and summarizes what it found, showing the sources behind each claim so you can check them. It is a Mayo Clinic Platform company with a physician advisory board, which is part of why it has been trusted and adopted so quickly across health systems.
The core idea is point of care evidence. You ask the kind of question that comes up on rounds, and you get a sourced answer in seconds rather than opening five tabs.
How do heme/onc fellows use OpenEvidence?
Heme/onc fellows use OpenEvidence most at the point of care, where the questions are specific and the answer needs a citation. A few patterns show up again and again.
Dosing and interactions: checking a regimen dose, a renal adjustment, or whether two drugs interact, with the source attached so you can trust it.
Next line decisions: when the first plan fails, asking what the evidence supports for second or third line therapy in a specific setting.
Tumor board and journal club prep: pulling the pivotal trial behind a recommendation quickly, so you walk in able to cite the data rather than just the conclusion.
Orienting to a new disease: getting a fast, sourced overview before a rotation or a new consult, then going deeper from the citations.
Is OpenEvidence free?
OpenEvidence is free for verified clinicians, including practicing physicians and medical students who confirm their status. That free access for the exact audience that uses it most is a big reason it has spread so quickly. There is no question bank style subscription to weigh here. The cost question is really about your time and trust, not your wallet.
What does OpenEvidence do well?
OpenEvidence does cited, point of care evidence better than anything else a fellow can pull up in seconds. The grounding is the key. Because every answer links back to named sources, you are not taking a chatbot at its word, you are reading a synthesis you can verify. On a busy consult service that is the difference between a tool you trust and one you do not.
It is also fast and conversational. You can ask a precise question, read the sourced answer, and ask a sharper follow up, all without breaking your workflow. For the specific job of answering a clinical question with evidence attached, it is excellent, and it is free.
Where does OpenEvidence fall short?
OpenEvidence falls short as a study tool, because it is built for clinical decision support, not structured curriculum learning. It answers the question in front of you rather than teaching you a disease area systematically or testing your recall, which is what moves an ITE or board score. Use it to answer questions, not to study for the exam.
The other limit is the one every AI tool shares. Even a citation grounded system can misread or overstate the evidence, and you can over trust a confident, well sourced looking answer. For anything high stakes, a dose, a sequencing decision, a trial result you are about to quote at tumor board, confirm it against the primary source. The citation is there precisely so you can check it, so check it.
OpenEvidence for answers, a question bank for boards
The cleanest way to think about OpenEvidence is as your point of care evidence tool, paired with a separate resource for board learning. OpenEvidence answers what does the evidence say right now. A question bank builds the pattern recognition and recall the boards test.
This is where MeDucation fits alongside it. MeDucation is a physician curated hematology-oncology question bank with long, detailed explanations that compare and contrast every answer choice, spaced repetition flashcards, and the ability to upload your ITE so your studying targets your weak areas. OpenEvidence makes you faster on service today; a tool like MeDucation makes you ready for the exam. Many fellows use both. For the full landscape, see our guide to the best AI tools for hematology-oncology fellows, our ASCO-SEP review, and our overview of how AI is changing oncology education. Disclosure: I founded MeDucation.
The verdict: is OpenEvidence worth it in 2026?
Yes. OpenEvidence is worth it for heme/onc fellows, it is free, and it deserves a place on your phone and in your workflow for fast, cited answers on rounds and at tumor board. Just keep its lane clear. Use it for point of care evidence, verify anything high stakes against the primary trial or guideline, and lean on a question bank for the systematic learning that boards reward. Used that way, it is one of the most useful free tools in medicine right now.
Frequently asked questions
Is OpenEvidence worth it for heme/onc fellows?
Yes. OpenEvidence is worth it for the point of care questions fellows face daily, dosing, interactions, next line options, and tumor board prep, because it returns cited answers in seconds and it is free for verified clinicians. It is not a board study tool, so pair it with a question bank for exam preparation.
Is OpenEvidence free?
OpenEvidence is free for verified clinicians, including physicians and medical students who confirm their status. There is no paid subscription tier for the core clinical question and answer tool, which is a major reason it has been adopted so widely.
Is OpenEvidence accurate?
OpenEvidence grounds its answers in cited literature, which makes it far more reliable than a general chatbot, but it is still an AI system and can misread or overstate evidence. Treat it as a fast, sourced starting point and verify high stakes details against the primary trial or guideline.
Can I use OpenEvidence to study for the boards?
Not as your main resource. OpenEvidence answers clinical questions rather than teaching a curriculum or testing recall, which is what board prep requires. Use it for evidence on service and use a question bank with spaced repetition for systematic board learning.
Who is behind OpenEvidence?
OpenEvidence is a Mayo Clinic Platform company with a physician advisory board, which is part of why it has earned clinician trust and spread quickly through hospitals.
Sources
OpenEvidence, New England Journal of Medicine, and MeducationAI.
